Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 25.14 USD -1.02% Market Closed
Market Cap: 3.4B USD

Wall Street
Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 35.8 USD with a low forecast of 16.16 USD and a high forecast of 58.8 USD.

Lowest
Price Target
16.16 USD
36% Downside
Average
Price Target
35.8 USD
42% Upside
Highest
Price Target
58.8 USD
134% Upside
Arcus Biosciences Inc Competitors:
Price Targets
DTIL
Precision BioSciences Inc
574% Upside
AUPH
Aurinia Pharmaceuticals Inc
7% Upside
2696
Shanghai Henlius Biotech Inc
57% Upside
LTRN
Lantern Pharma Inc.
445% Upside
2171
CARsgen Therapeutics Holdings Ltd
48% Upside
HRTX
Heron Therapeutics Inc
235% Upside
ALEC
Alector Inc
43% Upside
688428
InnoCare Pharma Ltd
59% Upside

Revenue
Forecast

Revenue Estimate
Arcus Biosciences Inc

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 3 years is -8%.

111%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCUS's stock price target?
Price Target
35.8 USD

According to Wall Street analysts, the average 1-year price target for RCUS is 35.8 USD with a low forecast of 16.16 USD and a high forecast of 58.8 USD.

What is Arcus Biosciences Inc's Revenue forecast?
Projected CAGR
-8%

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 3 years is -8%.

Back to Top